COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,895 Articles (22,568 medRxiv, 8,327 bioRxiv)

Most recent first Previous |  Page 1250: Articles 12491-12500  | Next

Dynamics of the Third wave, modelling COVID-19 pandemic with an outlook towards India
Basak, A., Rahaman, S., Guha, A., Sanyal, T.
10.1101/2021.08.17.21262193 — Posted: 2021-08-24
Symptoms and SARS-CoV-2 positivity in the general population in the UK
Vihta, K.-D., Pouwels, K. B., Peto, T., Pritchard, E., Eyre, D. W., House, T., Gethings, O., Studley, R., Rourke, E., Cook, D., Diamond, I., Crook, D., Matthews, P. C., Stoesser, N., Walker, A. S., COVID-19 Infection Survey team
10.1101/2021.08.19.21262231 — Posted: 2021-08-24
Federal Vaccine Policy and Interstate Variation in COVID-19 Vaccine Coverage in India
Mukherjee, K.
10.1101/2021.08.16.21262113 — Posted: 2021-08-24
Segregation of children into small groups for in-person learning during the COVID-19 pandemic
Munoz-Nava, L. M., Nahmad, M.
10.1101/2021.08.17.21261993 — Posted: 2021-08-24
Child Mortality in England During the First Year of the COVID-19 Pandemic
Odd, D. E., Stoianova, S., Williams, T., Fleming, P., Luyt, K.
10.1101/2021.08.23.21262114 — Posted: 2021-08-24
The SARS-CoV-2 Alpha variant is associated with increased clinical severity of disease
Pascall, D. J., Mollett, G., Blacow, R., Bulteel, N., Campbell, R., Campbell, A., Clifford, S., Davis, C., da Silva Filipe, A., Fjodorova, L., Forrest, R., Goldstein, E., Gunson, R., Haughney, J., Holden, M. T., Honour, P., Hughes, J., James, E., Lewis, T., Lycett, S. J., McHugh, M., Onishi, Y., Parcell, B., Robertson, D. L., El Sakka, N., Shabaan, S., Shepherd, J. G., Smollett, K., Templeton, K., Vink, E., Westnedge, E., Williams, T., The COVID-19 Genomics UK (COG-UK) consortium, , Thomson, E. C.
10.1101/2021.08.17.21260128 — Posted: 2021-08-24
Men are the main COVID-19 transmitters: lessons from couples
Silva, M. V. R., de Castro, M. V., Passos-Bueno, M. R., Otto, P. A., Naslavsky, M. S., Zatz, M.
10.1101/2021.08.18.21262187 — Posted: 2021-08-24
Association of cerebral venous thrombosis with recent COVID-19 vaccination: case-crossover study using ascertainment through neuroimaging in Scotland.
McKeigue, P. M., Burgul, R., Bishop, J., Robertson, C., McMenamin, J., O'Leary, M., McAllister, D. A., Colhoun, H. M.
10.1101/2021.08.23.21261779 — Posted: 2021-08-24
Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
Pouwels, K. B., Pritchard, E., Matthews, P., Stoesser, N. B., Eyre, D. W., Vihta, K.-D., House, T., Hay, J., Bell, J., Newton, J., Farrar, J., Crook, D. W., Cook, D., Rourke, E., Studley, R., Peto, T. E., Diamond, I., Walker, S., COVID-19 Infection Survey Team
10.1101/2021.08.18.21262237 — Posted: 2021-08-24 Discussion: Onsite
Assessing the impact of adherence to Non-pharmaceutical interventions and indirect transmission on the dynamics of COVID-19: a mathematical modelling study
Iyaniwura, S. A., Rabiu, M. A., David, J., Kong, J. D.
10.1101/2021.08.16.21262135 — Posted: 2021-08-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).